Switch to:
More From Other Websites
Is Vertex Pharmaceuticals Exposed to Drug Pricing Risks? Jul 22 2016
How Alexion Plans to Fuel Strensiq Sales Jul 22 2016
How Can Alexion Stay ahead of the Competition with Soliris? Jul 22 2016
Wall Street Looks for Vertex Pharmaceuticals to Break Even in 2Q16 Jul 21 2016
Analysts Gauge Alexion Pharmaceuticals’ Return Potential Jul 21 2016
Will Alexion Pharmaceuticals’ 2Q16 Earnings Surprise? Jul 21 2016
Biotech: Steak, But No Sizzle Jul 15 2016
Alexion Presents New SBC-103 (rhNAGLU enzyme) Phase 1/2 Data on Brain MRI and Neurocognitive... Jul 14 2016
Alexion Presents New SBC-103 (rhNAGLU enzyme) Phase 1/2 Data on Brain MRI and Neurocognitive... Jul 14 2016
Amazon Target Primed; Top Banks Initiated Ahead Of Earnings Jul 13 2016
Alexion Pharmaceuticals (ALXN) Stock Gets ‘Outperform’ Rating at RBC Capital Jul 13 2016
16 Recently Upgraded Stocks (APD,ALXN,ADP,BHI) Jul 13 2016
Biotech: 'We Would Not Be Surprised to See Volatility Continue' Jul 13 2016
[$$] Three Biotech Picks With Pipeline Upside Jul 13 2016
Coverage initiated on Alexion Pharma by RBC Capital Mkts Jul 13 2016
Stocks in record territory Jul 12 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK